Back on 20th Dec 21, the Office for National Statistics (ONS) published a dataset containing details on ‘deaths by vaccination status in England’ between 1st Jan and 31st Oct 21.
The ONS tabulated their “monthly age-standardised mortality rates by age-group and vaccination status for deaths per 100,000 person-years,” but presented only the data for individuals ages 18 and over.
The vaccinations, on the other hand, are available to children as young as 12, who were allowed to receive the injection against their parents’ wishes. In some cases, children as young as five have been given a reduced dosage of the vaccines.
However, on table 9 of the ‘Deaths by Vaccination Status’ dataset, the ONS have inadvertently provided enough details on deaths among children and teenagers by vaccination status for us to calculate the mortality rates ourselves.
The data showed a massive increase in deaths among single-vaccinated and double-vaccinated children compared to their unvaccinated counterparts. For children aged 15 to 19, the risk of death increases by 82% following the first shot, and a shocking 226% following the second shot.
But things are much worse for 10 to 14-year-olds. The risk of dying increases by a mind-blowing 885% following the first shot, and then an earth shattering 5105% following the second dose.
This means that children between 10 and 14, who had at least one shot of the Covid-19 vaccine, were 10 times more likely to die between January and October 2021, while children who had the second dose were 52 times more likely to die.
We also see this reflected in the figures for deaths among the age group which were also published by the ONS.
Deaths among children aged 10 to 14 had risen by 44 percent between 20th Sep (the first week following the roll-out of the vaccine to all in this age group) and 14th Nov 2021 compared to the five-year average between 2015 and 2019.
Risks clearly outweigh benefits of COVID vaccine among children
The Joint Committee on Vaccination and Immunisation (JCVI), an independent adviser to the U.K. government on the immunisation program, determined last year that the available evidence indicates that the individual health benefits from COVID-19 vaccination are small in children aged 12 to 15 years.
They also noted that any benefit granted by the shots is only “marginally greater” than other potential known harms. They also acknowledged that there is “considerable uncertainty regarding the magnitude of the potential harms.”
Due to the uncertainty of the risks involved with the Covid-19 injections, the JCVI considered the benefits too small to support advice on a universal program for vaccination of otherwise healthy 12- to 15-year-old children.
The still ongoing Covid-19 vaccine trials also never produced evidence that the vaccines prevent infection and transmission or reduce hospitalisations. Their measurement of success is in preventing severe symptoms of the virus, with strong evidence that the “vaccinated” can just as likely transmit the virus to others.
The former vice president and chief scientist for allergy and respiratory at Pfizer, stressed that the vaccines used against Covid-19 have not been sufficiently tested and that they shouldn’t have received emergency use authorisation when there are safe and effective medicines available for COVID-19.
Yeadon explained that the mRNA gene technology used in Pfizer’s COVID-19 vaccine to trigger the body to create viral spike proteins is a “fundamental problem” that scientists and researchers have known about for years. According to Yeadon, those spike proteins can lead to blood clots and other health problems.
Yeadon also said that young people are not susceptible to Covid-19, and “it’s a crazy thing to vaccinate them with something that is actually 50 times more likely to kill them than the virus itself.”
With official ONS data now showing children are 52 times more likely to die than unvaccinated children, it looks like Dr Mike Yeadon underestimated the true damage these experimental Covid-19 injections were about to cause.